Inventiva S.A. current report, Q1 FY2023

Inventiva S.A. — Form 6-K Summary

Reporting period and context: Inventiva S.A. filed Form 6-K for January 2023 on January 4, 2023. The filing reports that the company issued a press release dated January 4, 2023, furnished as Exhibit 99.1. The provided filing text does not include the substance of that press release.

Financial and Operating Information

The filing text does not provide clear figures for revenue, profit or loss, cash flow, margins, debt, liquidity, operating performance, or other financial metrics.

Material Changes Versus Prior Period

No operating, financial, or balance-sheet changes versus a comparable prior period are described in the provided text.

Guidance, Outlook, Risks, and Unusual Items

No guidance, outlook, management commentary, risks, contingencies, or unusual items are disclosed in the provided filing text. Any material information may be contained in Exhibit 99.1, which is not reproduced here.

Important Facts to Verify

  • Review Exhibit 99.1 for the underlying January 4, 2023 press release and any substantive company updates.
  • Determine whether the press release contains clinical, regulatory, financing, liquidity, or corporate developments.
  • Confirm whether any information in Exhibit 99.1 updates prior guidance or creates new financing, operational, or litigation risks.
  • The Form 6-K states that the filing and Exhibit 99.1 are incorporated by reference into Inventiva’s Form F-3 registration statement No. 333-258369, to the extent not superseded.